{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:23Z","timestamp":1790803283221,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Management of chalazion, characterized by noninfectious chronic granulomatous inflammation of the meibomian glands (MGs), remains challenging in ophthalmic practice, particularly because of its propensity for recurrence even after surgical intervention. This study aimed to evaluate the combined efficacy of doxycycline and intense pulsed light (IPL) therapy for treating intractable recurrent chalazion, focusing on reducing recurrence rates and improving MG status. This retrospective study included patients with intractable recurrent chalazion refractory to conventional treatments including surgical intervention and antibiotics. All patients were treated with a combination of doxycycline and IPL therapy. Clinical assessments included best-corrected visual activity, intraocular pressure, and MG evaluations using slit-lamp biomicroscopy and Keratograph 5\u2009M topography. The study included 12 patients (5 male and 7 female) with an average age of 36.3\u2009years. Treatment outcomes were categorized as \u2018success\u2019 (83.3%), \u2018stationary\u2019 (8.3%), and \u2018failure\u2019 (8.3%). Significant improvements were noted in the MG expression scores (<jats:italic>p<\/jats:italic> =\u20090.038), MG quality scores (<jats:italic>p<\/jats:italic>\u2009=\u20090.045), and lid margin telangiectasia scores (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). In addition, significant improvement in meiboscores was observed (<jats:italic>p<\/jats:italic> =\u20090.002). The combination of doxycycline and IPL therapy demonstrated promising efficacy in treating intractable recurrent chalazion, with significant improvements in MG function and reduced recurrence rates. This treatment approach offers a viable alternative for patients with recurrent chalazions, particularly for those who are unresponsive to conventional treatments.<\/jats:p>","DOI":"10.3389\/fmed.2024.1454049","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T04:27:38Z","timestamp":1727670458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of combined doxycycline and intense pulsed light therapy for the management of intractable recurrent chalazion"],"prefix":"10.3389","volume":"11","author":[{"given":"Hyeon-Jeong","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Young","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Chul","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jcjo.2021.04.023","article-title":"Chalazion: racial risk factors for formation, recurrence, and surgical intervention","volume":"57","author":"Evans","year":"2022","journal-title":"Can J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/02713683.2023.2279014","article-title":"Chalazion treatment: a concise review of clinical trials","volume":"49","author":"Tashbayev","year":"2024","journal-title":"Curr Eye Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3928\/01913913-20120720-03","article-title":"Management of recurrent chalazia","volume":"49","author":"Duss","year":"2012","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"839908","DOI":"10.3389\/fmed.2022.839908","article-title":"Efficacy of intense pulsed light in the treatment of recurrent chalaziosis","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"12393","DOI":"10.1038\/s41598-023-39332-x","article-title":"Novel treatment of chalazion using light-guided-tip intense pulsed light","volume":"13","author":"Zhu","year":"2023","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/bjophthalmol-2020-318420","article-title":"Prevalence and risk factors for chalazion in an older veteran population","volume":"106","author":"Patel","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.3390\/jcm11185338","article-title":"Therapeutic efficacy and safety of intense pulsed light for refractive multiple recurrent chalazia","volume":"11","author":"Arita","year":"2022","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"CD013559","DOI":"10.1002\/14651858.CD013559","article-title":"Intense pulsed light (IPL) therapy for the treatment of Meibomian gland dysfunction","volume":"3","author":"Cote","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.survophthal.2019.08.007","article-title":"Management of Meibomian gland dysfunction: a review","volume":"65","author":"Sabeti","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clae.2015.08.002","article-title":"On the prescribing of oral doxycycline or minocycline by UK optometrists as part of management of chronic Meibomian gland dysfunction (MGD)","volume":"39","author":"Doughty","year":"2016","journal-title":"Cont Lens Anterior Eye"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4103\/ijo.IJO_1244_17","article-title":"Oral azithromycin and oral doxycycline for the treatment of Meibomian gland dysfunction: a 9-month comparative case series","volume":"67","author":"De Benedetti","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jtos.2022.08.010","article-title":"Antibiotic treatment for dry eye disease related to Meibomian gland dysfunction and blepharitis\u2014a review","volume":"26","author":"Vernhardsdottir","year":"2022","journal-title":"Ocul Surf"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.phrs.2010.10.004","article-title":"Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action","volume":"63","author":"Griffin","year":"2011","journal-title":"Pharmacol Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ajo.2006.06.047","article-title":"Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics","volume":"142","author":"Cetinkaya","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/lsm.22566","article-title":"Side effects from intense pulsed light: importance of skin pigmentation, fluence level and ultraviolet radiation-a randomized controlled trial","volume":"49","author":"Thaysen-Petersen","year":"2017","journal-title":"Lasers Surg Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/pho.2017.4402","article-title":"Intense pulsed light applied directly on eyelids combined with Meibomian gland expression to treat Meibomian gland dysfunction","volume":"36","author":"Rong","year":"2018","journal-title":"Photomed Laser Surg"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3341\/jkos.2021.62.12.1581","article-title":"Efficacy of intense pulsed light treatment in patients with Sj\u00f6gren\u2019s syndrome associated with Meibomian gland dysfunction","volume":"62","author":"Moon","year":"2021","journal-title":"J Korean Ophthalmol Soc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","article-title":"The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee","volume":"52","author":"Tomlinson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12886-022-02261-w","article-title":"The association of demodex infestation with pediatric chalazia","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/00003226-200111000-00024","article-title":"Chalazion as a cause of decreased vision after LASIK","volume":"20","author":"Cosar","year":"2001","journal-title":"Cornea"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/09286586.2023.2199838","article-title":"Risk factors for Chalazion diagnosis and subsequent surgical excision","volume":"31","author":"Kim","year":"2024","journal-title":"Ophthal Epidemiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1368669","DOI":"10.3389\/fmolb.2024.1368669","article-title":"Genetic correlation between circulating metabolites and chalazion: a two-sample Mendelian randomization study","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Mol Biosci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3928\/01913913-20221025-02","article-title":"High load of demodex in young children with chalazia","volume":"60","author":"Xiao","year":"2023","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/ICO.0000000000002954","article-title":"Clinical and molecular outcomes after combined intense pulsed light therapy with low-level light therapy in recalcitrant evaporative dry eye disease with Meibomian gland dysfunction","volume":"41","author":"D'Souza","year":"2022","journal-title":"Cornea"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/photob.2022.0120","article-title":"A review of applications and intracellular mechanisms of intense pulsed light in eyelid inflammatory diseases","volume":"41","author":"Zeng","year":"2023","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1167\/iovs.10-6514","article-title":"Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction","volume":"52","author":"Borchman","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.3748\/wjg.v17.i28.3310","article-title":"Doxycycline blocks gastric ulcer by regulating matrix metalloproteinase-2 activity and oxidative stress","volume":"17","author":"Singh","year":"2011","journal-title":"World J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/ICO.0b013e318254205f","article-title":"Topical azithromycin and oral doxycycline therapy of Meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study","volume":"32","author":"Foulks","year":"2013","journal-title":"Cornea"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1454049\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T04:27:39Z","timestamp":1727670459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1454049\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":29,"alternative-id":["10.3389\/fmed.2024.1454049"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1454049","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"article-number":"1454049"}}